MODA Biotech

Established in 2018, Chongqing MODA Biotechnology Co., Ltd. is an innovative in vitro diagnosis (IVD) enterprise dedicated to developing, manufacturing, and selling IVD reagents and instruments. Our professional research team continuously develops new IVD products every year. MODA has a strong research and development team that prioritizes independent research. Under the leadership of Longcheng Yingcai and guided by the principles of truth-seeking, innovation, and human health, we have developed five automated detection platforms and 82 kits in different detection fields. Our clean workshop spans 1,700 square meters and includes four production lines. Our production management and quality management personnel have extensive experience in R&D and production of similar products. We constantly adjust our product structure and strengthen internal management to maintain a good development trend. MODA offers three major detection platforms: point-of-care testing (POCT), microfluidic biochemical detection, and molecular diagnostic detection. Our products cover inflammation detection, diabetes detection, cardiac marker detection, cancer detection, pregnancy detection, chronic disease detection, infectious disease detection, and other kit products and their supporting automated workstations. We have developed our own time-resolved fluorescence immunoassay (TRFIA) platform. Our rapid clinical diagnosis reagents based on TRFIA technology offer high sensitivity, accuracy, and a wide linear range. Our products cover cancer, infectious, cardiovascular, renal, gastric, autoimmune diseases, and more. We are devoted to the field of POCT, aiming to provide more rapid and accurate test methods to assist physicians in proposing more effective treatment options. MODA participates in international medical exhibitions every year. We have obtained CE certification, ISO 13485 quality system certification, production license, and marketing license of the origin country. FDA （2023）

• Employees 1
• Founded 2018